Medication use | Ethnic group |  |  χ2** | df |  P# | ||
---|---|---|---|---|---|---|---|
Malays | Chinese | Indians | Others* | ||||
Antiplatelets | Â | Â | Â | Â | Â | Â | Â |
Aspirin (%) | 6092 (94.4) | 2769 (94.1) | 2851 (94.2) | 649 (95.6) | 2.6 | 3 | 0.454 |
Other antiplatelets (%) | 4312 (68.5) | 2222 (77.0) | 2178 (73.0) | 440 (73.0) | 75.6 | 3 | 0.000 |
Anticoagulants | Â | Â | Â | Â | Â | Â | Â |
Heparin (%) | 907 (15.0) | 202 (7.3) | 281 (9.7) | 55 (9.8) | 128.9 | 3 | 0.000 |
LMWH (%) | 3340 (54.1) | 1882 (66.2) | 2033 (68.6) | 435 (68.5) | 282.1 | 3 | 0.000 |
Antihypertensives | Â | Â | Â | Â | Â | Â | Â |
β-blockers (%) | 4238 (67.6) | 2052 (71.2) | 2067 (69.5) | 418 (68.9) | 12.3 | 3 | 0.060 |
ACEI (%) | 3899 (62.4) | 1666 (58.4) | 1814 (61.1) | 337 (55.9) | 19.8 | 3 | 0.000 |
ARB (%) | 468 (7.8) | 242 (8.7) | 304 (10.5) | 59 (10.4) | 20.3 | 3 | 0.000 |
Diuretics (%) | 2016 (32.7) | 798 (28.3) | 888 (30.2) | 196 (33.2) | 19.8 | 3 | 0.000 |
CCB (%) | 895 (14.8) | 409 (14.7) | 509 (17.4) | 82 (14.5) | 12.1 | 3 | 0.007 |
Anti-diabetic agents | Â | Â | Â | Â | Â | Â | Â |
OHA (%) | 1599 (26.1) | 712 (25.4) | 1157 (39.3) | 112 (19.8) | 217.9 | 3 | 0.000 |
Insulin (%) | 1522 (24.7) | 586 (20.8) | 978 (33.1) | 104 (18.2) | 140.7 | 3 | 0.000 |
Statins | Â | Â | Â | Â | Â | Â | Â |
Statins (%) | 5833 (91.0) | 2700 (92.1) | 2737 (90.8) | 646 (95.1) | 16.6 | 3 | 0.001 |